Complete characterization of RNA biomarker fingerprints using a multi-modal ATR-FTIR and SERS approach for label-free early breast cancer diagnosis

With the multi-modal approach combining ATR-FTIR and SERS, we achieved an extended spectral range for molecular fingerprint detection of RNA biomarkers. Machine learning results shows 91.6% blind test accuracy for label-free breast cancer diagnosis.